Filter
319
Text search:
MDR-TB
Featured
Recommendations
26
New Publications
64
Language
Document type
No document type
233
Studies & Reports
32
Guidelines
21
Strategic & Response Plan
11
Fact sheets
9
Manuals
7
Training Material
3
Situation Updates
3
Countries / Regions
Western and Central Europe
25
Eastern Europe
19
India
10
Kenya
10
South Africa
8
Bangladesh
8
Rwanda
7
Malawi
7
Latin America and the Carribbean
7
Tanzania
5
Namibia
5
Ukraine
5
Myanmar / Burma
5
Asia
5
South–East Asia Region
4
Ghana
3
Nepal
3
Zambia
3
Peru
3
Lesotho
3
Tajikistan
3
Senegal
2
Ethiopia
2
Philippines
2
Germany
2
Cambodia
2
Mozambique
2
Benin
2
Venezuela
2
Russia
2
Global
2
Vietnam
2
Guinea
1
Burkina Faso
1
Sierra Leone
1
Liberia
1
Congo, Democratic Republic of
1
Uganda
1
Zimbabwe
1
Pakistan
1
South Sudan
1
Afghanistan
1
Indonesia
1
Central African Republic
1
Colombia
1
Botswana
1
Sri Lanka
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Paraguay
1
Bhutan
1
Armenia
1
Timor Leste/ East Timor
1
Georgia
1
Turkmenistan
1
Maldives
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
103
Clinical Guidelines
29
Public Health
6
Pharmacy & Technologies
4
Capacity Building
2
Key Resources
2
Women & Child Health
1
Toolboxes
TB
183
HIV
24
AMR
17
Polio
8
Conflict
5
Refugee
5
Global Health Education
4
COVID-19
3
NTDs
3
Pharmacy
2
Health Financing Toolbox
2
Disability
1
Ebola & Marburg
1
Natural Hazards
1
Rapid Response
1
Mental Health
1
Specific Hazards
1
Caregiver
1
Planetary Health
1
2.0 Rapid Response
1
How to make your messages on tuberculosis count
WHO/HTM/STB/2009.57
BUKO Pharma-Kampagne has investigated the causes and consequences of antibiotic resistance in India, South Africa, Tanzania and Germany. Together with our partners we collected data and did interviews with numerous stakeholders. The outcome is presented in a brochure that is now available in English
...
TB in India 2017
recommended
Revised National TB Control Programme. Annual Status Report
Antibiotics and other antimicrobial agents are invaluable life savers, particularly in resource-limited countries where infectious diseases are abundant. Both uncomplicated and severe infections are potentially curable as long as the aetiological agents are susceptible to the
...
WHO would like to express its gratitude and appreciation to all Member States that provided information to the WHO survey on policies and activities at the national level in the area of antimicrobial resistance. The contribution of staff in WHO Regional and Country Offices has been invaluable: in ga
...
Addressing comorbidities and risk factors for tuberculosis (TB) is a crucial component of the World Health Organization (WHO)’s End TB Strategy. This WHO operational handbook on tuberculosis. Module 6: tuberculosis and comorbidities aims to support countries in scaling up people-centred care,
...
Joining efforts to control two trelated global epidemics.
Technical Guidelines for Integrated Disease Surveillance and Response in the African Region
recommended
3rd edition.
The third edition of the Integrated Disease Surveillance and Response (IDSR) Technical Guidelines was prepared by the WHO Health Emergencies (WHE) Programme with the active participation and involvement of programmes dealing with disease surveillance at the WHO Regional Office for Afri
...
A manual for programme managers.
The End TB Strategie
The development of the Country Cooperation Strategy (CCS) was based on a consultative and participatory process with strong commitment and support from the Ministry of Health of Ghana. The CCS draws on lessons from the implementation of the first, and second generation CCSs, the country focus strate
...
The purpose of the landscape analysis is ultimately to facilitate improved engagement of private providers, thereby contributing to universal access to quality and affordable TB care and the end of the TB epidemic. It focuses on the role of private for-profit providers and on specific challenges and
...
